AI Terminal
Evonik Industries AG
M&A Activity • Mar 6, 2018
150_rns_2018-03-06_ced597bc-8e8b-42d0-bf24-c6fc3c98e3b0.html
M&A Activity
Open in ViewerOpens in native device viewer
News Details
Ad-hoc | 6 March 2018 06:48
Evonik Industries AG: Evonik Industries AG announces divestment of methacrylates business
Evonik Industries AG / Key word(s): Disposal
Evonik Industries AG: Evonik Industries AG announces divestment of methacrylates business
06-March-2018 / 06:48 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP – a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Essen, 6 March 2018. The Executive Board of Evonik Industries AG has resolved today to evaluate all options for the future development of the methacrylates business. These options include potential partnerships and complete divestment.
The Group is therefore taking the next step in the ongoing development of its portfolio. Evonik is systematically implementing its strategy of sharpening its focus on specialty chemicals and is concentrating on its four defined growth engines. In this way Evonik is aiming for a more balanced portfolio to ensure optimal allocation of its resources. Its growth engines are health & care, smart materials, specialty additives, and animal nutrition. They have above-average growth and low cyclical exposure. The methacrylates business, which is part of the Performance Materials segment, is outside Evonik’s defined growth areas.
The methacrylates business comprises high-volume monomers such as MMA, various specialty monomers as well as the PLEXIGLAS(R) brand of PMMA molding compounds and semi-finished products. These products are manufactured at various locations in Germany, North America and Asia.
In business year 2017 Evonik generated around 40 percent of the sales of the Performance Materials segment with its methacrylates business.
Contact/person making the notification:
Tim Lange
Head of Investor Relations
+49 201 177-3150
06-March-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
| Language: | English |
| Company: | Evonik Industries AG |
| Rellinghauser Straße 1-11 | |
| 45128 Essen | |
| Germany | |
| Phone: | +49 (0) 201 177-01 |
| Fax: | +49 (0) 201 177-3475 |
| E-mail: | [email protected] |
| Internet: | www.evonik.com |
| ISIN: | DE000EVNK013, XS0911405784 |
| WKN: | EVNK01, A1TM7T |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange; Luxemburg |
| End of Announcement | DGAP News Service |